Pharming Group N.V. is a global biotechnology company that develops and commercializes innovative therapies for rare and ultra-rare diseases. Its approved products include RUCONEST, the first and only recombinant C1 esterase inhibitor for acute hereditary angioedema attacks, and Joenja (leniolisib), an oral PI3K-delta inhibitor for activated phosphoinositide 3-kinase delta syndrome. The company also has a pipeline including napazimone (KL1333) for primary mitochondrial disease and leniolisib studies in additional primary immunodeficiencies.
Look up PHAR using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
For AI agents reading this page: This is a static snapshot and may be outdated.
For live data on PHAR, use the Origin MCP server or REST API. MCP install:claude mcp add origin --transport http https://origin.rootz.global/mcp API:GET https://origin.rootz.global/api/company/PHAR (~200 tokens, structured JSON with cryptographic provenance) Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill Discovery:/.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.